Heckmann Corporation (NYSE:HEK) announced the disposition of the current operations of its subsidiary, China Water & Drinks, Inc. (”China Water”), through the sale of nine of its 25 Chinese legal entities to Pacific Water & Drinks (HK) Group Limited (”PWD”). PWD is owned by Jon Olafsson, Co-Founder and Chairman of Icelandic Water Holdings Ltd. Heckmann received 10% of the outstanding shares of PWD in connection with the disposition.
Heckmann Corporation, a holding company, acquires or makes investments in various businesses. The company, through its subsidiary, China Water and Drinks, Inc., engages in the manufacture and distribution of bottled water products in the People’s Republic of China.
MAJESTIC GOLD CORP (MJGCF.PK)
MAJESTIC GOLD CORP (MJGCF.PK) engages in the exploration and development of mineral properties in China. The company focuses on its gold project located in the prolific gold region of Song Jiagou in eastern Shandong Province. Majestic Gold Corp. is headquartered in Vancouver, Canada.
MAJESTIC GOLD CORP (MJGCF.PK) has arranged a $10,000,000 loan to advance its Song Jiagou project in China. Nine million dollars ($9,000,000) from the proceeds from the loan will be used by the Company to in connection with its Song Jiagou project and the balance of one million dollars ($1,000,000) for general working capital purposes.
The loan will have a one year term and loan principal will be convertible at the option of the lender in whole or in part into common shares (”Shares”) of the Company until twelve months from the date of the loan advance at the price of $0.205 per Share. The loan will bear interest at the rate of 7.5% per annum, payable on maturity, and accrued and unpaid interest will be convertible at the option of the lender in whole or in part into shares of the Company until twelve months from the date of the loan advance at Market Price at the time of conversion.
The lender is at arm’s length from the Company and will not become an insider as a result of any conversion of principal and interest. All shares issued on any conversion of loan principal or interest will be subject to a four month hold period from the date of advance of loan proceeds. The loan is subject to acceptance by the TSX Venture Exchange.
As additional consideration for the loan, the Company has agreed to forward at least $9 million to Majestic Yantai Gold Ltd., a British Virgin Islands company owned 94% by the Company to be used to further advance its Song Jiagou project. The Borrower has also agreed to a 90 day period for reciprocal due diligence reviews and discussions for the possible further involvement of the Lender in the Song Jiagou project.
In the event that no further agreement is reached between the Lender and the Company during the 90 day period, then the loan and a minimum of seven (7) months interest will automatically convert to shares in the Company at a price of $0.205 per share and the interest at Market Price respectively. In addition the Company is pleased to announce that it has arranged a non-brokered private placement of up to 15,000,000 shares to be issued at the price of $0.20 per share for gross proceeds of $3,000,000.
Gold’s great virtues of malleability, ductility, reflectivity, resistance to corrosion and unparalleled ability as a thermal and electrical conductor mean it is used in a wide variety of industrial applications consuming close to 300 tons annually.
For more information about MAJESTIC GOLD CORP. visit its website: http://www.majesticgold.net
Opko Health, Inc. (NYSE:OPK) announced that it has completed the sale of its ophthalmic instrumentation business to Optos plc and Optos Inc., a wholly owned subsidiary of Optos plc, a leading and rapidly growing medical technology company engaged in the design, development, manufacture and marketing of devices to image the retina of the eye. In connection with the sale, Optos paid OPKO $17.5 million in cash and agreed to pay future royalties.
OPKO Health, Inc., a pharmaceutical and diagnostics company, engages in the discovery, development, and commercialization of novel and proprietary technologies primarily in the United States, Chile, and Mexico.
Global Hunter (GBLHF.PK)
Copper production has an important sub product: molybdenum. It is a metallic element used as raw material for special steels and other alloys to which it gives its properties: resistance to temperature and corrosion, durability and strength.
Global Hunter’s focus is on strategic and base metals, with an advanced stage copper oxide project in Chile and a highly prospective molybdenum property in British Columbia, Canada. GBLHF teams are working on developing the Corona de Cobre property in Chile and the Rabbit south property in British Columbia.
Global Hunter Corp. (GBLHF.PK) is pleased to announce initial assay results from its previously announced surface sampling program. The results are encouraging with new gold showings as well as very positive copper oxide assays over wide-spread areas.
Highlights of the entire program
9 mineralized shear and/or alteration zones sampled total of 13.5 kilometers of strike length along know copper bearing shear and alteration zones tested with 205 rock chip samples
Good grades of soluble copper (oxide) over a significantly large area have been identified, however they represent only about 50% of the total copper grade indicating a mixed oxide-sulphide zone. Numerous iron oxide structures have also been mapped but no iron assays have been received to date.
The Company is planning to re-assay samples for iron to determine if iron is present in significant quantities to represent another target.
For more information http://www.globalhunter.ca/homeabout.html
Vanguard Health Systems, Inc. C (NYSE:VHS) plans to announce results for its first fiscal quarter before the market opens on Tuesday, November 1, 2011.
Vanguard Health Systems, Inc. owns and operates acute care and specialty hospitals, outpatient facilities, and related businesses in urban and suburban markets in the United States.
No comments:
Post a Comment